Future Healthcare Of America (FUTU) Tops Q2 EPS by 49c

Future Healthcare Of America (NASDAQ: FUTU) reported Q2 EPS of HK$8.66, HK$0.49 better than the analyst estimate of HK$8.17. Revenue for the quarter came in at HK$3.13 billion versus the consensus estimate of HK$2.85 billion.

For earnings history and earnings-related data on Future Healthcare Of America (FUTU) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• PreveCeutical closes second tranche of private placement for $245,000
• TechCreate Group faces NYSE American delisting proceedings